POLM
DNA-directed DNA/RNA polymerase mu
Also known as: DPOLM_HUMAN, Tdt-N
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NP87
- Gene
- POLM
- Ensembl
- ENSG00000122678
- Chromosome
- 7
- Canonical length
- 494 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to enable DNA-directed DNA polymerase activity. Predicted to be involved in double-strand break repair via nonhomologous end joining. Predicted to act upstream of or within B cell differentiation and somatic hypermutation of immunoglobulin genes. Predicted to be located in nucleoplasm. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
494 residues, UniProt reviewed canonical sequence.
>Q9NP87|POLM
1 MLPKRRRARV GSPSGDAASS TPPSTRFPGV AIYLVEPRMG RSRRAFLTGL ARSKGFRVLD
61 ACSSEATHVV MEETSAEEAV SWQERRMAAA PPGCTPPALL DISWLTESLG AGQPVPVECR
121 HRLEVAGPRK GPLSPAWMPA YACQRPTPLT HHNTGLSEAL EILAEAAGFE GSEGRLLTFC
181 RAASVLKALP SPVTTLSQLQ GLPHFGEHSS RVVQELLEHG VCEEVERVRR SERYQTMKLF
241 TQIFGVGVKT ADRWYREGLR TLDDLREQPQ KLTQQQKAGL QHHQDLSTPV LRSDVDALQQ
301 VVEEAVGQAL PGATVTLTGG FRRGKLQGHD VDFLITHPKE GQEAGLLPRV MCRLQDQGLI
361 LYHQHQHSCC ESPTRLAQQS HMDAFERSFC IFRLPQPPGA AVGGSTRPCP SWKAVRVDLV
421 VAPVSQFPFA LLGWTGSKLF QRELRRFSRK EKGLWLNSHG LFDPEQKTFF QAASEEDIFR
481 HLGLEYLPPE QRNALocalizationUniProt · AlphaFold · HPA
Whether an antibody against POLM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- spleen: 12 nTPM
- kidney: 11 nTPM
- liver: 9.6 nTPM
- thymus: 9.1 nTPM
- thyroid gland: 9.1 nTPM
- pancreas: 8.9 nTPM
Single-cell type
- esophageal apical cells: 53 nCPM
- tuft cells: 46 nCPM
- neutrophils: 43 nCPM
- rod photoreceptor cells: 41 nCPM
- b-cells: 36 nCPM
- breast lactating cells: 34 nCPM
Immune cell
- neutrophil: 64 nTPM
- basophil: 24 nTPM
- naive B-cell: 11 nTPM
- eosinophil: 11 nTPM
- plasmacytoid DC: 9.6 nTPM
- memory B-cell: 8 nTPM
Brain region
- midbrain: 8 nTPM
- thalamus: 7.9 nTPM
- pons: 6.5 nTPM
- medulla oblongata: 6.4 nTPM
- cerebellum: 6.2 nTPM
- amygdala: 5.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.1
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.19
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell differentiation
- DNA recombination
- double-strand break repair via nonhomologous end joining
- somatic hypermutation of immunoglobulin genes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- BRCT domain
- DNA nucleotidylexotransferase (TdT) / DNA-directed DNA/RNA polymerase mu
- DNA-directed DNA polymerase X
- Crossover junction endonuclease MUS81-like, HHH domain
- DNA polymerase lambda, fingers domain
- DNA polymerase family X, binding site
- DNA polymerase family X
- DNA polymerase lambda lyase domain superfamily
- DNA polymerase beta, palm domain
- DNA polymerase beta, thumb domain
- BRCT domain superfamily
- DNA polymerase, thumb domain superfamily
- Nucleotidyltransferase superfamily
- Fingers domain of DNA polymerase lambda
- Helix-hairpin-helix domain
- DNA polymerase beta thumb
- DNA polymerase beta palm
- DNA-directed DNA/RNA polymerase mu
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads POLM as an antibody target. Whether an autoantibody or antibody against POLM could matter depends on whether native POLM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
POLM is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label POLM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...